Application of Clinical Pathway for Community-Acquired Pneumonia_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

ZHU Yinggang , QU Jieming

Corresponding author：

Keywords：

临床路径; 社区获得性肺炎

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

社区获得性肺炎( CAP) 是严重威胁人类健康的常见疾病之一, 但在其诊断和治疗仍存在相当大的差异。临床路径( clinical pathway, CP) 是一种新的临床诊疗规范管理方式,
近年来开始应用于CAP 的临床诊治, 陆续有协会组织开始制定关于CAP 的临床路径, 并应用于临床。

Citation： ZHU Yinggang,QU Jieming. Application of Clinical Pathway for Community-Acquired Pneumonia. Chinese Journal of Respiratory and Critical Care Medicine, 2010, 9(1): 97-99. doi: Copy

1.	Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America.Clin Infect Dis,2000,31:347-382.
2.	Hauck LD,Adler LM,Mulla ZD.Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia.Ann Epidemiol,2004,14:669-675.
3.	Lave JR,Lin CJ,Hughes CP,et al.The cost of treating patients with community-acquired pneumonia.Semin Respir Crit Care Med,1999,20:189-197.
4.	龚棣.介绍一种新的医疗护理模式——临床路径.现代医院管理,2004,2:42-44.
5.	吴袁俞云,英立平.临床路径实施手册.北京:北京医科大学出版社,2002.
6.	王冬,董军,朱士俊.临床路径——临床医疗的标准化管理模式.医院管理论坛,2003,19:38-42.
7.	Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.
8.	Meehan TP,Weingarten SR,Holmboe ES,et al.A statewide initiative to improve the care of hospitalized pneumonia patients:The Connecticut Pneumonia Pathway Project.Am J Med,2001,111:203-210.
9.	Marrie TJ,Lau CY,Wheeler SL,et al.A controlled trial of a critical pathway for treatment of community-acquired pneumonia.CAPITAL Study Investiga tors.Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.JAMA,2000,283:749-755.
10.	Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part I:the nursing perspective.J Am Med Dir Assoc,2006,7:271-278.
11.	Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part II:the administrators’ perspective and how it differs from nurses’ views.J Am Med Dir Assoc,2006,7:279-286.
12.	孙宏永,徐峰,徐志豪,等.社区获得性肺炎临床路径的初步探讨.浙江医学,2007,29:805-806.
13.	Barlow G,Nathwani D,Williams F,et al.Reducing door-to-antibiotic time in community-acquired pneumonia:Controlled before-and-after evaluation and cost-effectiveness analysis.Thorax,2007,62:67-74.
14.	Ramirez JA. Switch therapy in community-acquired pneumonia. Diagn Microbiol Infect Dis,1995,22: 219-223.
15.	Moeller JJ,Ma M,Hernandez P,et al.Discharge Delay in Patients with Community-acquired Pneumonia Managed on a Critical Pathway.Can J Infect Dis Med Microbiol,2006,17:109-113.
16.	Masotti L,Ceccarelli E,Cappelli R,et al.Length of hospitalization in elderly patients with community-acquired pneumonia.Aging (Milano),2000,12:35-41.
17.	Brancati FL,Chow JW,Wagener MM,,et al.Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia.Lancet,1993,342:30-33.
18.	Marrie TJ.Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.Chemotherapy,2004,50 suppl 1:11-15.
19.	Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
20.	Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis,2007,44 Suppl 2:S27-72.
21.	Moran G.Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.J Emerg Med,2006,30:377-387.

1. Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America.Clin Infect Dis,2000,31:347-382.
2. Hauck LD,Adler LM,Mulla ZD.Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia.Ann Epidemiol,2004,14:669-675.
3. Lave JR,Lin CJ,Hughes CP,et al.The cost of treating patients with community-acquired pneumonia.Semin Respir Crit Care Med,1999,20:189-197.
4. 龚棣.介绍一种新的医疗护理模式——临床路径.现代医院管理,2004,2:42-44.
5. 吴袁俞云,英立平.临床路径实施手册.北京:北京医科大学出版社,2002.
6. 王冬,董军,朱士俊.临床路径——临床医疗的标准化管理模式.医院管理论坛,2003,19:38-42.
7. Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.
8. Meehan TP,Weingarten SR,Holmboe ES,et al.A statewide initiative to improve the care of hospitalized pneumonia patients:The Connecticut Pneumonia Pathway Project.Am J Med,2001,111:203-210.
9. Marrie TJ,Lau CY,Wheeler SL,et al.A controlled trial of a critical pathway for treatment of community-acquired pneumonia.CAPITAL Study Investiga tors.Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.JAMA,2000,283:749-755.
10. Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part I:the nursing perspective.J Am Med Dir Assoc,2006,7:271-278.
11. Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part II:the administrators’ perspective and how it differs from nurses’ views.J Am Med Dir Assoc,2006,7:279-286.
12. 孙宏永,徐峰,徐志豪,等.社区获得性肺炎临床路径的初步探讨.浙江医学,2007,29:805-806.
13. Barlow G,Nathwani D,Williams F,et al.Reducing door-to-antibiotic time in community-acquired pneumonia:Controlled before-and-after evaluation and cost-effectiveness analysis.Thorax,2007,62:67-74.
14. Ramirez JA. Switch therapy in community-acquired pneumonia. Diagn Microbiol Infect Dis,1995,22: 219-223.
15. Moeller JJ,Ma M,Hernandez P,et al.Discharge Delay in Patients with Community-acquired Pneumonia Managed on a Critical Pathway.Can J Infect Dis Med Microbiol,2006,17:109-113.
16. Masotti L,Ceccarelli E,Cappelli R,et al.Length of hospitalization in elderly patients with community-acquired pneumonia.Aging (Milano),2000,12:35-41.
17. Brancati FL,Chow JW,Wagener MM,,et al.Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia.Lancet,1993,342:30-33.
18. Marrie TJ.Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.Chemotherapy,2004,50 suppl 1:11-15.
19. Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
20. Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis,2007,44 Suppl 2:S27-72.
21. Moran G.Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.J Emerg Med,2006,30:377-387.

Chinese Journal of Respiratory and Critical Care Medicine

Application of Clinical Pathway for Community-Acquired Pneumonia

Abstract Full text Figures/Tables Video References Cited by

Format

Content